MarketScreener Homepage > Equities > Australian Stock Exchange > Mayne Pharma Group Limited MYX AU000000MYX0

Report

End-of-day quote Australian Stock Exchange - 01/25
0.35	AUD		+1.45%

01/06

MAYNE PHARMA : Launches Pregnancy Prevention Tablets in US

01/06

MAYNE PHARMA : launches Microgestin 24 FE tablets in the US

01/06

MAYNE PHARMA : 07/01/2021 Mayne Pharma launches Microgestin® 24 Fe tablets in the United States

News

All News

Official Publications

Sector news

All news about MAYNE PHARMA GROUP LIMITED

01/06	MAYNE PHARMA : Launches Pregnancy Prevention Tablets in US	MT
01/06	MAYNE PHARMA : launches Microgestin 24 FE tablets in the US	PU
01/06	MAYNE PHARMA : 07/01/2021 Mayne Pharma launches Microgestin® 24 Fe tablets in th..	PU
2020	MAYNE PHARMA : Extends Three-Year Bullet Facility	MT
2020	MAYNE PHARMA : 18/12/2020 Mayne Pharma successfully extends debt facility	PU
2020	MAYNE PHARMA : successfully extends debt facility	PU
2020	MAYNE PHARMA : 24/11/2020 2020 AGM Chairman's Address	PU
2020	MAYNE PHARMA : 24/11/2020 2020 AGM CEO's Speech	PU
2020	MAYNE PHARMA : 09/11/2020 Mayne Pharma Board Renewal	PU
2020	MAYNE PHARMA : Board Renewal	PU
2020	MAYNE PHARMA : New data on Mayne Pharma's TOLSURA presented at IDWeek 2020	AQ
2020	MAYNE PHARMA : 26/10/2020 New data on Mayne Pharma's TOLSURA presented at IDWeek..	PU
2020	MAYNE PHARMA : Lapse of rights and AGM Notice of Meeting clarification	PU
2020	MAYNE PHARMA : 2020 Annual General Meeting	PU
2020	MAYNE PHARMA : 2020 Corporate Governance Statement	PU
2020	MAYNE PHARMA : Annual Report to shareholders	PU
2020	Mithra Announces FDA update	AQ
2020	MAYNE PHARMA : provides update on Women's Health pipeline	AQ
2020	MAYNE PHARMA : 06/10/2020 Mayne Pharma provides update on Women's Health pipelin..	PU
2020	MAYNE PHARMA : Appoints Chief Financial Officer	AQ
2020	MAYNE PHARMA : appoints new CFO	PU
2020	MAYNE PHARMA : 29/09/2020 Mayne Pharma Appoints Chief Financial Officer	PU
2020	MAYNE PHARMA : Appendix 4E and Statutory Accounts	PU
2020	MAYNE PHARMA : 2020 Full Year Media Release	PU
2020	MAYNE PHARMA : 2020 Full Year Investor Presentation	PU
2020	MAYNE PHARMA : 21/08/2020 Mayne Pharma FY20 Results Media Release	PU
2020	MAYNE PHARMA : Announces strategic partnership with novast	AQ
2020	MAYNE PHARMA : Announces Expansion of US Production Space	AQ
2020	Mithra Announces FDA Filing Acceptance of New Drug Application for Estelle in..	AQ
2020	MAYNE PHARMA : Announces FDA Filing Acceptance of New Drug Application for E4/DR..	AQ
2020	MAYNE PHARMA : Toni Nesci named head of Mayne Contract Services and New Website ..	AQ
2020	MAYNE PHARMA : signs license agreement for contraceptive in Australia	AQ
2020	MAYNE PHARMA : submits NDA for E4/DRSP to the FDA	AQ
2020	MAYNE PHARMA : Resignation of group chief financial officer and appointment of i..	AQ
2020	MAYNE PHARMA : 20/03/2020 Change of CFO and Company Secretary	PU
2020	MAYNE PHARMA : 2020 Half Year Media Release	PU
2020	MAYNE PHARMA : Half Yearly Report and Accounts	PU
2020	MAYNE PHARMA : 2020 Half Year Investor Presentation	PU
2020	MAYNE PHARMA : 21/02/2020 Mayne Pharma 2020 Half Year Media Release	PU
2020	MAYNE PHARMA GROUP LIMITED : half-yearly earnings release
2019	MAYNE PHARMA : Aspires To Specialisation	AQ
2019	MAYNE PHARMA : Final Director's Interest Notice	PU
2019	MAYNE PHARMA : 22/11/2019 2019 AGM CEO's Speech	PU
2019	MAYNE PHARMA : 22/11/2019 2019 AGM Chairman's Address	PU
2019	MAYNE PHARMA : 2019 AGM CEO's Speech	PU
2019	MAYNE PHARMA : 2019 AGM Chairman's Address	PU
2019	MAYNE PHARMA : 23/10/2019 E4/DRSP contraceptive presented at EU gynecology confe..	PU
2019	MAYNE PHARMA : E4/DRSP contraceptive presented at EU gynecology conference	PU
2019	MAYNE PHARMA : Retirement of Director	PU
2019	MAYNE PHARMA : 21/10/2019 Retirement of Director	PU
2019	MAYNE PHARMA : 21/10/2019 Notice of Annual General Meeting/Proxy Form	PU
2019	MAYNE PHARMA : Change of Director's Interest Notice (x2)	PU
2019	MAYNE PHARMA : 2019 Annual Report	PU
2019	MAYNE PHARMA : Appendix 4G and Corporate Governance Statement	PU
2019	MAYNE PHARMA : MYX signs license agreement for novel oral contraceptive	PU
2019	MAYNE PHARMA : 02/10/2019 Mayne Pharma signs 20-year license agreement for novel..	PU
2019	MAYNE PHARMA : Lapse of employee options	PU
2019	MAYNE PHARMA : Appendix 4E and Full Year Statutory Accounts	PU
2019	MAYNE PHARMA : 2019 Full Year Results Media Release	PU
2019	MAYNE PHARMA : 2019 Full Year Results Investor Presentation	PU
2019	MAYNE PHARMA : 23/08/2019 FY19 Results Media Release	PU
2019	MAYNE PHARMA : Lapse of employee options	PU
2019	MAYNE PHARMA : market update	PU
2019	MAYNE PHARMA : investor presentation to Goldmans conference	PU
2019	MAYNE PHARMA : Half Year Accounts	PU
2019	MAYNE PHARMA : 2019 Half Year Investor Presentation	PU
2019	MAYNE PHARMA : 22/02/2019 HY19 Results Media Release	PU
2019	MAYNE PHARMA GROUP LTD : half-yearly earnings release
2019	MAYNE PHARMA : announces new indication for Kapanol by TGA	PU
2019	MAYNE PHARMA : 19/02/2019 Mayne Pharma Announces New Chronic Breathlessness Indi..	PU
2019	MAYNE PHARMA : Lexette (halobetasol) foam now launched in the US	PU
2019	MAYNE PHARMA : 13/02/2019 Mayne Pharma Launches Lexette™ (Halobetasol Prop..	PU
2019	MAYNE PHARMA : Tolsura (SUBA-itraconazole) capsule now launched in the US	PU
2018	MAYNE PHARMA : MYX extends debt facility and adds receivables facility	PU
2018	MAYNE PHARMA : 20/12/2018 Mayne Pharma extends debt facility and adds receivable..	PU

1 2 3 Next

Upcoming event on MAYNE PHARMA GROUP LIMITED

02/19/21

Interim 2021 Earnings Release (Projected)

Company calendar

Upcoming sector events

01/26/21	JOHNSON & JOHNSON : FY 2020 Earnings Release
01/26/21	NOVARTIS AG : FY 2020 Earnings Release
01/28/21	LUPIN LIMITED : Q3 2021 Earnings Release
01/28/21	SUMITOMO DAINIPPON PHARMA CO., LTD. : Q3 2020 Earnings Release

More events

Sector

Healthcare
	Pharmaceuticals & Medical Research
		Pharmaceuticals
			Pharmaceuticals
				Specialty & Advanced Pharmaceuticals